| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 38 |
| 1 | METHOTREXATE SODIUM | 38 |
| 2 | METHOTREXATE | 29 |
| 3 | DEXAMETHASONE | 23 |
| 4 | DEXAMETHASONE 1.5 MG | 23 |
| 5 | ETANERCEPT | 23 |
| 6 | CYCLOPHOSPHAMIDE | 20 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 20 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 20 |
| 9 | RITUXIMAB | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AURANOFIN | 1 | 0.0049 |
| 1 | BELINOSTAT | 1 | 0.0028 |
| 2 | AMPHETAMINE SULFATE TABLETS | 3 | 0.0017 |
| 3 | ROMIDEPSIN | 2 | 0.0012 |
| 4 | DASATINIB | 11 | 0.0012 |
| 5 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 6 | INOTUZUMAB OZOGAMICIN | 3 | 0.0010 |
| 7 | CLOFARABINE | 2 | 0.0009 |
| 8 | IDELALISIB | 6 | 0.0009 |
| 9 | ACYCLOVIR SODIUM | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 49 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 40 |
| 2 | Thalidomide Analog [EPC] | 38 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 30 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 29 |
| 5 | Kinase Inhibitor [EPC] | 27 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 7 | Alkylating Drug [EPC] | 24 |
| 8 | Benzodiazepine [EPC] | 19 |
| 9 | BCL-2 Inhibitor [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | CD22-directed Immunoconjugate [EPC] | 3 | 0.0010 |
| 2 | Histone Deacetylase Inhibitor [EPC] | 3 | 0.0008 |
| 3 | Blood Viscosity Reducer [EPC] | 2 | 0.0005 |
| 4 | Anthelmintic [EPC] | 1 | 0.0003 |
| 5 | BCL-2 Inhibitor [EPC] | 18 | 0.0003 |
| 6 | Nonergot Dopamine Agonist [EPC] | 4 | 0.0003 |
| 7 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 8 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 9 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |